These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6943332)

  • 1. Anthracycline assay by high-pressure liquid chromatography.
    Averbuch SD; Finkelstein TT; Fandrich SE; Reich SD
    J Pharm Sci; 1981 Mar; 70(3):265-9. PubMed ID: 6943332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid quantitative determination of doxorubicin and its metabolites in biological samples.
    Sqalli A; Labat C; Oustrin J; Houin G; Coulais Y; Bugat R; Carton P
    Ann Biol Clin (Paris); 1989; 47(2):63-6. PubMed ID: 2735565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid quantitative determination of seven anthracyclines and their hydroxy metabolites in body fluids.
    Oosterbaan MJ; Dirks RJ; Vree TB; van der Kleijn E
    J Chromatogr; 1984 Mar; 306():323-32. PubMed ID: 6585367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.
    Andrews PA; Brenner DE; Chou FT; Kubo H; Bachur NR
    Drug Metab Dispos; 1980; 8(3):152-6. PubMed ID: 6104578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loop-column extraction and liquid chromatographic analysis of doxorubicin and three metabolites in plasma.
    Riley CA; Crom WR; Evans WE
    Ther Drug Monit; 1985; 7(4):455-60. PubMed ID: 4082243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantitation of plasma doxorubicin and prochlorperazine content by high-performance liquid chromatography.
    Mou C; Ganju N; Sridhar KS; Krishan A
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 703(1-2):217-24. PubMed ID: 9448079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma.
    Fogli S; Danesi R; Innocenti F; Di Paolo A; Bocci G; Barbara C; Del Tacca M
    Ther Drug Monit; 1999 Jun; 21(3):367-75. PubMed ID: 10365655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High performance liquid chromatography determination of doxorubicin and daunorubicin in plasma using UV detection and column switching.
    Mikan A; Martinez Lanao J; Gonzalez Lopez F; Dominguez-Gil Hurle A
    Biomed Chromatogr; 1990 Jul; 4(4):154-6. PubMed ID: 2207376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatography of iodo-doxorubicin and fluorescent metabolites in plasma samples.
    Mross K; Mayer U; Hamm K; Hossfeld DK
    J Chromatogr; 1990 Aug; 530(1):192-9. PubMed ID: 2277112
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitation of daunorubicin and its metabolites by high-performance liquid chromatography with electrochemical detection.
    Akpofure C; Riley CA; Sinkule JA; Evans WE
    J Chromatogr; 1982 Nov; 232(2):377-83. PubMed ID: 7153284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of doxorubicin, daunorubicin, and idarubicin by capillary electrophoresis with laser-induced fluorescence detection.
    Pérez-Ruiz T; Martínez-Lozano C; Sanz A; Bravo E
    Electrophoresis; 2001 Jan; 22(1):134-8. PubMed ID: 11197162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved HPLC method for doxorubicin quantification in rat plasma to study the pharmacokinetics of micelle-encapsulated and liposome-encapsulated doxorubicin formulations.
    Wei G; Xiao S; Si D; Liu C
    Biomed Chromatogr; 2008 Nov; 22(11):1252-8. PubMed ID: 18651589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro.
    Takahashi RH; Bains OS; Pfeifer TA; Grigliatti TA; Reid RE; Riggs KW
    Drug Metab Dispos; 2008 Jun; 36(6):991-4. PubMed ID: 18322072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of daunorubicin, doxorubicin and their fluorescent metabolites by high-pressure liquid chromatography: plasma levels in DBA2 mice.
    Baurain R; Deprez-De Campeneere D; Trouet A
    Cancer Chemother Pharmacol; 1979; 2(1):11-4. PubMed ID: 498412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid Chromatography-Tandem Mass Spectrometry for the Simultaneous Determination of Doxorubicin and its Metabolites Doxorubicinol, Doxorubicinone, Doxorubicinolone, and 7-Deoxydoxorubicinone in Mouse Plasma.
    Choi WG; Kim DK; Shin Y; Park R; Cho YY; Lee JY; Kang HC; Lee HS
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32164308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatography.
    van Asperen J; van Tellingen O; Beijnen JH
    J Chromatogr B Biomed Sci Appl; 1998 Aug; 712(1-2):129-43. PubMed ID: 9698235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of plasma concentrations of epirubicin and its metabolites by high-performance liquid chromatography during a 96-h infusion in cancer chemotherapy.
    Barker IK; Crawford SM; Fell AF
    J Chromatogr B Biomed Appl; 1996 Jun; 681(2):323-9. PubMed ID: 8811443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of adriamycin, adriamycinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography.
    Cummings J; Stuart JF; Calman KC
    J Chromatogr; 1984 Nov; 311(1):125-33. PubMed ID: 6520153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative nuclear and cellular incorporation of daunorubicin, doxorubicin, carminomycin, marcellomycin, aclacinomycin A and AD 32 in daunorubicin-sensitive and -resistant Ehrlich ascites in vitro.
    Seeber S; Loth H; Crooke ST
    J Cancer Res Clin Oncol; 1980; 98(2):109-18. PubMed ID: 6938517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography.
    Bolanowska W; Gessner T; Preisler H
    Cancer Chemother Pharmacol; 1983; 10(3):187-91. PubMed ID: 6574828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.